Ignace Vergote
33PUBLICATIONS
333CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (33)
Sort by Publication Date:
|Oct 30, 2025
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors.Kristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem
|May 28, 2025
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 Consortium.Nicole Concin, Ioana Braicu, Pierre Combe
|Dec 14, 2024
Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA‑1/ENGOT-ov25.Coline Montégut, Claire Falandry, Saverio Cinieri
|Dec 05, 2024
Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials.Hailei Zhang, Anna Rutkowska, Antonio González-Martín
|Apr 16, 2024
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design.Ignace Vergote, Alejandro Perez Fidalgo, Giorgio Valabrega
|Mar 28, 2024
TIM3 Checkpoint Inhibition Fails to Prolong Survival in Ovarian Cancer-Bearing Mice.Yani Berckmans, Ann Vankerckhoven, Aarushi Audhut Caro
Pageof 6
Frequent Collaborators
6 joint publications
Bradley J Monk
5 joint publications
Jalid Sehouli
5 joint publications
David Cibula
5 joint publications
Isabelle Ray-Coquard
4 joint publications
Eric Pujade-Lauraine
4 joint publications
Mansoor Raza Mirza
3 joint publications
Todd Edwards
3 joint publications
An Coosemans
3 joint publications
Regina Berger
3 joint publications
Robert L Coleman
